Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
07/2003
07/02/2003EP1322324A2 Methods for treating muscle injuries
07/02/2003EP1322323A1 Thionin as an antineoplastic and immunostimulant
07/02/2003EP1322319A1 Use of il-8 protein modulators in the treatment of viral infections
07/02/2003EP1322317A1 Compositions and methods for prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with compositions comprising unfractionated cellular proteins
07/02/2003EP1322292A2 Microparticle compositions and methods for the manufacture thereof
07/02/2003EP1322291A1 Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight
07/02/2003EP1322290A1 Vaccine composition comprising an immunologically active substance embedded in microparticles consisting of starch with reduced molecular weight
07/02/2003EP1322288A1 Inducing cellular immune responses to hepatitis b virus using peptide and nucleic acid compositions
07/02/2003EP1322287A2 Microparticles for delivery of the heterologous nucleic acids
07/02/2003EP0900025B1 Moraxella catarrhalis outer membrane protein omp106, gene sequence and uses thereof
07/02/2003EP0826043B1 Methods for modulating t cell survival by modulating bcl-xl protein level
07/02/2003EP0758375B1 Method to identify immunocompromised patients at high risk for cryptococcosis titrating the level of igg antibodies against glucoronoxylomannan
07/02/2003EP0732875B1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
07/02/2003EP0654089B1 Recombinant equine herpesviruses
07/02/2003CN1427892A Virulence genes, proteins and their use
07/02/2003CN1427889A Hybrid cells obtainable from antigen presenting cells
07/02/2003CN1427726A Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy
07/02/2003CN1427715A Urogenital or anorectal transmucosal vaccine delivery system
07/02/2003CN1426816A Veterinarian virus kind biological product heat resisting freeze drying protective agent and its preparation technique
07/02/2003CN1426814A Foreign duck liver ichthyophthirius active vaccine and its preparation method
07/02/2003CN1113097C Processes for preparation of Marek's disease virus using continuous mammalian cell lines
07/02/2003CN1112934C Epidemic hemorrhagic fever passage cell polyvalent purified vaccine
07/01/2003US6586580 Protein rib, a cell surface protein that confers immunity to many strains of the group B Streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
07/01/2003US6586578 Deformylase (def1); isolated polynucleotide of given sequence; detects Staphylococcus aureus; can use to screen for antibiotics
07/01/2003US6586572 Compositions and methods for the therapy and diagnosis of breast cancer
07/01/2003US6586570 Compositions and methods for the treatment and diagnosis of breast cancer
07/01/2003US6586569 Endometriosis-associated gene
07/01/2003US6586568 Purified viral polypeptide comprising amino acid sequence encoded by positive stranded RNA genome which comprises an open reading frame encoding a polyprotein; use in diagnosing and providing safer blood and organ supply
07/01/2003US6586424 Anticancer agents; anticholesterol agents
07/01/2003US6586423 Tyrosine kinase inhibitors
07/01/2003US6586412 Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
07/01/2003US6586409 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines
07/01/2003US6586397 Polypeptides encoding tyrosine kinase containing immunoglobulin and endithelial growth factor homology domains; induce vascularization
07/01/2003US6586242 TAO protein kinases and methods of use therefor
07/01/2003US6586191 Isolated nucleic acids encoding mammalian galanin receptors, isolated galanin receptor proteins, vectors comprising isolated nucleic acid encoding a mammalian galanin receptor, cells comprising such vectors, antibodies directed to a
07/01/2003US6586185 Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances
07/01/2003US6586173 Antibodies; protecting animals from diseases caused by filariids; fluorescent or colorimetric tagged enzyme substrate
07/01/2003US6586003 Emulsion and micellar formulations for the delivery of biologically active substances to cells
07/01/2003US6585981 The Mycoplasma hyopneumoniae grows at 34 degrees C. but does not grow at 38.5 - 39.5 degrees C.
07/01/2003US6585980 Flagellin gene, FlaC of Campylobacter
07/01/2003US6585978 EIA vaccine and diagnostic
07/01/2003US6585976 Selected from Mycobacterium tuberculosis species and Mycobacterium bovis species, and wherein said strain is incapable of expressing the product of the active erp gene
07/01/2003US6585973 Solid phase adjuvant methodology is used to synthesize a hapten-protein-polysaccharide conjugate vaccines to stimulate an anti- polysaccharide antibody response in infants who are otherwise unable to respond to polysaccharide alone
07/01/2003CA2122338C Novel human cdc25 genes, encoded products and uses therefor
07/01/2003CA2080548C Monoclonal antibodies to hepatitis c virus
07/01/2003CA2067469C Recombinant vaccine against marek's disease
06/2003
06/26/2003WO2003052124A2 Screening method for agents useful in treating diabetes
06/26/2003WO2003052122A2 Gp41 inhibitor
06/26/2003WO2003052076A2 Identification of essential genes of cryptococcus neoformans and methods of use
06/26/2003WO2003052051A2 Adeno-associated virus (aav) serotype 8 sequences
06/26/2003WO2003052048A2 Nucleic acid-associated proteins
06/26/2003WO2003051917A2 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
06/26/2003WO2003051914A2 Ides, an igg-degrading enzyme of streptococcus pyogenes
06/26/2003WO2003051913A2 Antigens for actinobacillus pleuropneumoniae and methods thereof
06/26/2003WO2003051912A2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
06/26/2003WO2003051907A2 Method of enhancing immunogenicity by covalent linkage of antigens to proteins on the surface of dendritic cells
06/26/2003WO2003051454A2 Methods for particle-assisted polynucleotide immunization using a pulsed electric field
06/26/2003WO2003051401A2 Stabilised mrna tumour vaccine
06/26/2003WO2003051396A1 Treating vascular disease by inhibiting myeloid differentiation factor 88
06/26/2003WO2003051394A2 Calcium phosphate particles as mucosal adjuvants
06/26/2003WO2003051393A2 Enzymatic cleavable reagents for specific delivery to disease sites
06/26/2003WO2003051392A2 Streptococcus pneumoniae vaccine
06/26/2003WO2003051383A2 Use of hmgb proteins and nucleic acids that code therefor
06/26/2003WO2003051379A1 Outer membrane vesicles from gram negative bacteria and use as a vaccine
06/26/2003WO2003051361A1 Use of hiv-1 protease inhibitors and their derivatives in the treatment of inflammation
06/26/2003WO2003051310A2 Methods of inhibiting fertility
06/26/2003WO2003051307A2 Materials and methods for the treatment or prevention of obesity
06/26/2003WO2003051305A2 Innate immune system-directed vaccines
06/26/2003WO2003051288A2 Mycobacterial vaccine
06/26/2003WO2003051285A2 Therapeutic anti-hiv (iv9) compounds
06/26/2003WO2003051272A2 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR GnRH-I AND GnRH-II MODULATION OF T-CELL ACTIVITY, ADHESION, MIGRATION AND EXTRAVASATION
06/26/2003WO2003051180A2 METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS USING 252, 304, 19870, 14717, 9941, 19310 and 17832
06/26/2003WO2003022306A3 Bacterial vaccine
06/26/2003WO2003015702A3 Epitopes of human immunodeficiency virus-1
06/26/2003WO2003000721A3 Mycobacterial antigens expressed under low oxygen tension
06/26/2003WO2002102855A3 In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
06/26/2003WO2002079240A3 Intimins for the prevention or treatment of infections: i
06/26/2003WO2002069369A3 Cpg-like nucleic acids and methods of use thereof
06/26/2003WO2002064766A3 Bax-responsive genes for drug target identification in yeast and fungi
06/26/2003WO2002044406A3 Projection against mycobacterial infections
06/26/2003WO2002042329A3 Compositions and methods relating to prostate specific genes and proteins
06/26/2003WO2002032378A9 Fusion cells and cytokine compositions for treatment of disease
06/26/2003WO2002018608A3 Methods for enhancing the efficacy of cancer therapy
06/26/2003WO2002004493A3 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
06/26/2003WO2001090154A3 Compositions and methods for the therapy and diagnosis of ovarian cancer
06/26/2003US20030120060 Induce immunology response; generating neutralizing antibodies
06/26/2003US20030120059 Cell surface molecule-induced macrophage activation
06/26/2003US20030120053 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030120052 Human genetic engineering; cancer diagnosis; hybrid nucleic acid
06/26/2003US20030119856 Thiazole compounds useful as inhibitors of protein kinase
06/26/2003US20030119797 Methods for selective immunomodulation
06/26/2003US20030119784 Treating and preventing diarrhea and scours
06/26/2003US20030119782 Method of treating and preventing infectious diesases
06/26/2003US20030119774 Compositions and methods for stimulating an immune response
06/26/2003US20030119773 Method for enhancing an immune response
06/26/2003US20030119764 Analog is incorporated by a polymerase into an RNA copy of a genomic nucleic acid encoding the virus, and replaces a first natural occurring nucleotide having a first complementary nucleotide
06/26/2003US20030119763 Compounds and methods for therapy and diagosis of lung cancer
06/26/2003US20030119743 Pharmaceutical composition comprising factor VII polypeptides and tissue plasminogen inhibitors
06/26/2003US20030119726 P-glycoproteins and uses thereof
06/26/2003US20030119719 Use of endothelin conjugates in therapy, new endothelin conjugates, agents that contain the latter, and process for their production
1 ... 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 ... 1823